340 related articles for article (PubMed ID: 8782652)
1. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
Reubi JC; Waser B
Int J Cancer; 1996 Sep; 67(5):644-7. PubMed ID: 8782652
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
5. CCK receptors in human neuroendocrine tumors: clinical implications.
Reubi JC
Scand J Clin Lab Invest Suppl; 2001; 234():101-4. PubMed ID: 11713969
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cholecystokinin 2-receptor in normal human thyroid gland and medullary thyroid carcinoma.
Blaker M; de Weerth A; Tometten M; Schulz M; Höppner W; Arlt D; Hoang-Vu C; Dralle H; Terpe H; Jonas L; von Schrenck T
Eur J Endocrinol; 2002 Jan; 146(1):89-96. PubMed ID: 11751073
[TBL] [Abstract][Full Text] [Related]
9. Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer.
Amiri-Mosavi A; Ahlman H; Tisell LE; Wängberg B; Kölby L; Forssell-Aronsson E; Lundberg PA; Lindstedt G; Nilsson O
Eur J Surg; 1999 Jul; 165(7):628-31. PubMed ID: 10452255
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
11. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors.
Huang SC; Yu DH; Wank SA; Mantey S; Gardner JD; Jensen RT
Peptides; 1989; 10(4):785-9. PubMed ID: 2479932
[TBL] [Abstract][Full Text] [Related]
12. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
13. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
[TBL] [Abstract][Full Text] [Related]
14. High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.
Schaer JC; Reubi JC
J Clin Endocrinol Metab; 1999 Jan; 84(1):233-9. PubMed ID: 9920090
[TBL] [Abstract][Full Text] [Related]
15. Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.
Behr TM; Jenner N; Radetzky S; Béhe M; Gratz S; Yücekent S; Raue F; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):424-30. PubMed ID: 9553173
[TBL] [Abstract][Full Text] [Related]
16. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor.
Miyake A; Mochizuki S; Kawashima H
Biochem Pharmacol; 1994 Apr; 47(8):1339-43. PubMed ID: 8185642
[TBL] [Abstract][Full Text] [Related]
18. Biology of gut cholecystokinin and gastrin receptors.
Shulkes A; Baldwin GS
Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-CCK-B type receptors on human T lymphoblastoid Jurkat cells.
Dornand J; Roche S; Michel F; Bali JP; Cabane S; Favero J; Magous R
Am J Physiol; 1995 Mar; 268(3 Pt 1):G522-9. PubMed ID: 7900813
[TBL] [Abstract][Full Text] [Related]
20. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
Singh P; Owlia A; Espeijo R; Dai B
J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
